238 related articles for article (PubMed ID: 18574646)
21. The Role of Ursodeoxycholic Acid (UDCA) in Cholelithiasis Management After One Anastomosis Gastric Bypass (OAGB) for Morbid Obesity: Results of a Monocentric Randomized Controlled Trial.
Pizza F; D'Antonio D; Lucido FS; Tolone S; Del Genio G; Dell'Isola C; Docimo L; Gambardella C
Obes Surg; 2020 Nov; 30(11):4315-4324. PubMed ID: 32583297
[TBL] [Abstract][Full Text] [Related]
22. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials.
Stokes CS; Gluud LL; Casper M; Lammert F
Clin Gastroenterol Hepatol; 2014 Jul; 12(7):1090-1100.e2; quiz e61. PubMed ID: 24321208
[TBL] [Abstract][Full Text] [Related]
23. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.
Shi J; Wu C; Lin Y; Chen YX; Zhu L; Xie WF
Am J Gastroenterol; 2006 Jul; 101(7):1529-38. PubMed ID: 16863557
[TBL] [Abstract][Full Text] [Related]
24. Ursodeoxycholic acid for the prevention of gallstone and subsequent cholecystectomy following gastric surgery: A systematic review and meta-analysis.
Choi JH; Lee SH; Cho IR; Paik WH; Ryu JK; Kim YT
J Hepatobiliary Pancreat Sci; 2021 May; 28(5):409-418. PubMed ID: 33768730
[TBL] [Abstract][Full Text] [Related]
25. Ursodeoxycholic acid for primary biliary cirrhosis.
Gong Y; Huang ZB; Christensen E; Gluud C
Cochrane Database Syst Rev; 2008 Jul; (3):CD000551. PubMed ID: 18677775
[TBL] [Abstract][Full Text] [Related]
26. Ursodeoxycholic acid for the prevention of gall stones after laparoscopic sleeve gastrectomy: a prospective controlled study.
Salman MA; Salman A; Mohamed US; Hussein AM; Ameen MA; Omar HSE; Elewa A; Hamdy A; Elias AA; Tourky M; Helal A; Mahmoud AA; Aljarad F; Moustafa A; Shaaban HE; Nashaat A; Hussein AM; Omar T; Balamoun H
Surg Endosc; 2022 Sep; 36(9):6396-6402. PubMed ID: 35020052
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of ursodeoxycholic acid as an adjuvant treatment to prevent acute cellular rejection after liver transplantation: a meta-analysis of randomized controlled trials.
Deng YL; Xiong XZ; Cheng NS
Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):464-73. PubMed ID: 25308356
[TBL] [Abstract][Full Text] [Related]
28. Cholelithiasis After Sleeve Gastrectomy and Effectiveness of Ursodeoxycholic Acid Treatment.
Şen O; Türkçapar AG; Yerdel MA
J Laparoendosc Adv Surg Tech A; 2020 Nov; 30(11):1150-1152. PubMed ID: 32228343
[No Abstract] [Full Text] [Related]
29. The use of Ursolit for gallstone prophylaxis following bariatric surgery: a randomized-controlled trial.
Sakran N; Dar R; Assalia A; Neeman Z; Farraj M; Sherf-Dagan S; Gralnek IM; Hazzan R; Mokary SE; Nevo-Aboody H; Dola T; Kaplan U; Hershko D
Updates Surg; 2020 Dec; 72(4):1125-1133. PubMed ID: 32666477
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery.
Haal S; Guman MSS; Bruin S; Schouten R; van Veen RN; Fockens P; Dijkgraaf MGW; Hutten BA; Gerdes VEA; Voermans RP
Obes Surg; 2022 Apr; 32(4):1270-1278. PubMed ID: 35143012
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
Kong X; Kong Y; Zhang F; Wang T; Yan J
Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
[TBL] [Abstract][Full Text] [Related]
32. Gallbladder management in obesity surgery.
Mason EE; Renquist KE
Obes Surg; 2002 Apr; 12(2):222-9. PubMed ID: 11975217
[TBL] [Abstract][Full Text] [Related]
33. Ursodeoxycholic acid for prevention of gallstone disease after laparoscopic sleeve gastrectomy: an Atlantic Canada perspective.
Hossain I; Brodie J; O'Brien E; Tedman-Aucoin K; Lawlor D; Murphy R; Twells L; Pace D; Evans B; Ellsmere J
Surg Endosc; 2023 Jul; 37(7):5236-5240. PubMed ID: 36952047
[TBL] [Abstract][Full Text] [Related]
34. Gallstone disease: Primary and secondary prevention.
Venneman NG; van Erpecum KJ
Best Pract Res Clin Gastroenterol; 2006; 20(6):1063-73. PubMed ID: 17127188
[TBL] [Abstract][Full Text] [Related]
35. Role of ursodeoxycholic acid in the prevention of gallstone formation after laparoscopic sleeve gastrectomy.
Abdallah E; Emile SH; Elfeki H; Fikry M; Abdelshafy M; Elshobaky A; Elgendy H; Thabet W; Youssef M; Elghadban H; Lotfy A
Surg Today; 2017 Jul; 47(7):844-850. PubMed ID: 27837275
[TBL] [Abstract][Full Text] [Related]
36. Ursodeoxycholic acid in the prevention of gallstones in patients subjected to Roux-en-Y gastric bypass1.
Machado FHF; Castro Filho HF; Babadopulos RFAL; Rocha HAL; Rocha JLC; Moraes Filho MO
Acta Cir Bras; 2019 Feb; 34(1):e20190010000009. PubMed ID: 30785510
[TBL] [Abstract][Full Text] [Related]
37. Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass.
Scott DJ; Villegas L; Sims TL; Hamilton EC; Provost DA; Jones DB
Surg Endosc; 2003 Nov; 17(11):1796-802. PubMed ID: 12958683
[TBL] [Abstract][Full Text] [Related]
38. Cholelithiasis after bariatric surgery, incidence, and prophylaxis: randomized controlled trial.
Talha A; Abdelbaki T; Farouk A; Hasouna E; Azzam E; Shehata G
Surg Endosc; 2020 Dec; 34(12):5331-5337. PubMed ID: 31858245
[TBL] [Abstract][Full Text] [Related]
39. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss.
Worobetz LJ; Inglis FG; Shaffer EA
Am J Gastroenterol; 1993 Oct; 88(10):1705-10. PubMed ID: 8213711
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of ursodeoxycholic acid treatment in the prevention of gallstone formation after laparoscopic sleeve gastrectomy.
Alimoğulları M; Buluş H
Acta Chir Belg; 2021 Apr; 121(2):109-114. PubMed ID: 33252027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
